International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Lett 30: [Related article:] 597, 2025; DOI: 10.3892/ol.2025.15343
Subsequently to the publication of the above paper, an interested reader drew to the Editor's attention that a pair of data panels shown for the scratch-wound assay experiments in Figs. 1 and 7 were apparently overlapping; in addition, another pair of data panels within Fig. 7 itself were also found to be overlapping.
Upon examining their original raw data (which were also presented to the Editorial Office for our inspection), the authors realized that several inadvertent errors had been made in the presentation of Figs. 2 and 7 in the published paper. Specifically, the image for the 24 h, SACC-LM Control (CON) group in Fig. 7 was inadvertently duplicated and used for the 24 h, negative control (NC-S100A4) group of the same cell line. Secondly, the image intended for the 24 h, SACC-LM sh-ILK group in Fig. 7 had mistakenly been replaced by an image from a separate sh-ILK experiment performed with the SACC-83 cells. Thirdly, the western blot data depicting ILK and Snail expression in the SACC-83 cell line in Fig. 2 were inadvertently re-used to represent different experimental endpoints in Figs. 3 and 6.
The revised versions of Figs. 2 and 7, featuring the correct data for the ILK and Snail blots for the SACC-83 cell line in Fig. 2, and the correct data for the 24 h, NC-S100A4 and 24 h, sh-ILK experiments for the SACC-LM cell line in Fig. 7, are shown on the next two pages. The authors regret these errors were made in compiling these figures, which resulted from administrative oversights during the image selection and integration process, although note that these errors did not grossly affect either the results or the conclusions reported in this study. The authors are grateful to the editor of Oncology Letters for allowing them the opportunity to publish a Corrigendum; furthermore, they apologize to the readership for any inconvenience caused.